Direct reprogramming—The future of cardiac regeneration?

International Journal of Molecular Sciences

Volumn 16, Issue 8, 2015, Pages 17368-17393

  Doppler, Stefanie A ^a   Deutsch, Marcus André ^a   Lange, Rüdiger ^a,b   Krane, Markus ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Direct reprogramming; Gata4; Induced cardiomyocytes (iCMs); Mef2c; Tbx5 (GMT); Transdifferentiation

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; 6 [[2 [[4 (2,4 DICHLOROPHENYL) 5 (4 METHYL 1H IMIDAZOL 2 YL) 2 PYRIMIDINYL]AMINO]ETHYL]AMINO]NICOTINONITRILE; BONE MORPHOGENETIC PROTEIN; FORSKOLIN; KRUPPEL LIKE FACTOR 4; MICRORNA; MYOCYTE ENHANCER FACTOR 2; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR TBX5; TRANYLCYPROMINE; TROPONIN T; TRANSCRIPTION FACTOR;

CARDIAC REGENERATION; CARDIAC STEM CELL; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; CONGESTIVE HEART FAILURE; EPIGENETICS; FIBROBLAST; GENE EXPRESSION REGULATION; HEART MUSCLE CELL; HEART TRANSPLANTATION; HUMAN; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; REVIEW; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; VIRAL GENE DELIVERY SYSTEM; ANIMAL; CARDIAC MUSCLE CELL; CYTOLOGY; GENE THERAPY; GENETICS; HEART FAILURE; METABOLISM; PHYSIOLOGY; REGENERATION;

ANIMALS; CELLULAR REPROGRAMMING; FIBROBLASTS; GENETIC THERAPY; HEART FAILURE; HUMANS; MICRORNAS; MYOCYTES, CARDIAC; REGENERATION; TRANSCRIPTION FACTORS;

EID: 84938400291     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms160817368     Document Type: Review

References (61)

1. Muraoka, N.; Ieda, M. Direct reprogramming of fibroblasts into myocytes to reverse fibrosis. Annu. Rev. Physiol. 2014, 76, 21-37.
2. Qian, L.; Srivastava, D. Direct cardiac reprogramming: From developmental biology to cardiac regeneration. Circ. Res. 2013, 113, 915-921.
3. Yi, B. A.; Mummery, C. L.; Chien, K. R. Direct cardiomyocyte reprogramming: A new direction for cardiovascular regenerative medicine. Cold Spring Harb. Perspect. Med. 2013, 3, a014050.
4. Doppler, S. A.; Deutsch, M. A.; Lange, R.; Krane, M. Cardiac regeneration: Current therapies-future concepts. J. Thorac. Dis. 2013, 5, 683-697.
5. Chen, J. X.; Plonowska, K.; Wu, S. M. Somatic cell reprogramming into cardiovascular lineages. J. Cardiovasc. Pharmacol. Ther. 2014, 19, 340-349.
6. Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126, 663-676.
7. Gurdon, J. B.; Elsdale, T. R.; Fischberg, M. Sexually mature individuals of xenopus laevis from the transplantation of single somatic nuclei. Nature 1958, 182, 64-65.
8. Davis, R. L.; Weintraub, H.; Lassar, A. B. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987, 51, 987-1000.
9. Muraoka, N.; Yamakawa, H.; Miyamoto, K.; Sadahiro, T.; Umei, T.; Isomi, M.; Nakashima, H.; Akiyama, M.; Wada, R.; Inagawa, K.; et al. MiR-133 promotes cardiac reprogramming by directly repressing snai1 and silencing fibroblast signatures. EMBO J. 2014, 33, 1565-1581.
10. Zhou, Q.; Brown, J.; Kanarek, A.; Rajagopal, J.; Melton, D. A. In vivo reprogramming of adult pancreatic exocrine cells to β-cells. Nature 2008, 455, 627-632.
11. Vierbuchen, T.; Ostermeier, A.; Pang, Z. P.; Kokubu, Y.; Sudhof, T. C.; Wernig, M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010, 463, 1035-1041.
12. Huang, P.; He, Z.; Ji, S.; Sun, H.; Xiang, D.; Liu, C.; Hu, Y.; Wang, X.; Hui, L. Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature 2011, 475, 386-389.
13. Sekiya, S.; Suzuki, A. Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. Nature 2011, 475, 390-393.
14. Batta, K.; Florkowska, M.; Kouskoff, V.; Lacaud, G. Direct reprogramming of murine fibroblasts to hematopoietic progenitor cells. Cell Rep. 2014, 9, 1871-1884.
15. Ieda, M.; Fu, J. D.; Delgado-Olguin, P.; Vedantham, V.; Hayashi, Y.; Bruneau, B. G.; Srivastava, D. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010, 142, 375-386.
16. Banerjee, I.; Fuseler, J. W.; Price, R. L.; Borg, T. K.; Baudino, T. A. Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse. Am. J. Physiol. Heart Circ. Physiol. 2007, 293, H1883-H1891.
17. Ieda, M.; Tsuchihashi, T.; Ivey, K. N.; Ross, R. S.; Hong, T. T.; Shaw, R. M.; Srivastava, D. Cardiac fibroblasts regulate myocardial proliferation through β1 integrin signaling. Dev. Cell 2009, 16, 233-244.
18. Van Wijk, B.; van den Hoff, M. Epicardium and myocardium originate from a common cardiogenic precursor pool. Trends Cardiovasc. Med. 2010, 20, 1-7.
19. Weintraub, H.; Tapscott, S. J.; Davis, R. L.; Thayer, M. J.; Adam, M. A.; Lassar, A. B.; Miller, A. D. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of myod. Proc. Natl. Acad. Sci. USA 1989, 86, 5434-5438.
20. Chien, K. R.; Yi, B. A.; Xu, H.; Mummery, C. L. Cardiomyocyte reprogramming and the new age of cellular alchemy. J. Mol. Cell. Cardiol. 2012, 53, 311-313.
21. Protze, S.; Khattak, S.; Poulet, C.; Lindemann, D.; Tanaka, E. M.; Ravens, U. A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells. J. Mol. Cell. Cardiol. 2012, 53, 323-332.
22. Song, K.; Nam, Y. J.; Luo, X.; Qi, X.; Tan, W.; Huang, G. N.; Acharya, A.; Smith, C. L.; Tallquist, M. D.; Neilson, E. G.; et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 2012, 485, 599-604.
23. Chen, J. X.; Krane, M.; Deutsch, M. A.; Wang, L.; Rav-Acha, M.; Gregoire, S.; Engels, M. C.; Rajarajan, K.; Karra, R.; Abel, E. D.; et al. Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5. Circ. Res. 2012, 111, 50-55.
24. Jayawardena, T. M.; Egemnazarov, B.; Finch, E. A.; Zhang, L.; Payne, J. A.; Pandya, K.; Zhang, Z.; Rosenberg, P.; Mirotsou, M.; Dzau, V. J. MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ. Res. 2012, 110, 1465-1473.
25. Addis, R. C.; Ifkovits, J. L.; Pinto, F.; Kellam, L. D.; Esteso, P.; Rentschler, S.; Christoforou, N.; Epstein, J. A.; Gearhart, J. D. Optimization of direct fibroblast reprogramming to cardiomyocytes using calcium activity as a functional measure of success. J. Mol. Cell. Cardiol. 2013, 60, 97-106.
26. Christoforou, N.; Chellappan, M.; Adler, A. F.; Kirkton, R. D.; Wu, T.; Addis, R. C.; Bursac, N.; Leong, K. W. Transcription factors MYOCD, SRF, MESP1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming. PLoS ONE 2013, 8, e63577.
27. Ifkovits, J. L.; Addis, R. C.; Epstein, J. A.; Gearhart, J. D. Inhibition of TGFβ signaling increases direct conversion of fibroblasts to induced cardiomyocytes. PLoS ONE 2014, 9, e89678.
28. Nam, Y. J.; Lubczyk, C.; Bhakta, M.; Zang, T.; Fernandez-Perez, A.; McAnally, J.; Bassel-Duby, R.; Olson, E. N.; Munshi, N. V. Induction of diverse cardiac cell types by reprogramming fibroblasts with cardiac transcription factors. Development 2014, 141, 4267-4278.
29. Wang, L.; Liu, Z.; Yin, C.; Asfour, H.; Chen, O.; Li, Y.; Bursac, N.; Liu, J.; Qian, L. Stoichiometry of Gata4, Mef2c, and Tbx5 influences the efficiency and quality of induced cardiac myocyte reprogramming. Circ. Res. 2015, 116, 237-244.
30. Efe, J. A.; Hilcove, S.; Kim, J.; Zhou, H.; Ouyang, K.; Wang, G.; Chen, J.; Ding, S. Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat. Cell Biol. 2011, 13, 215-222.
31. Wang, H.; Cao, N.; Spencer, C. I.; Nie, B.; Ma, T.; Xu, T.; Zhang, Y.; Wang, X.; Srivastava, D.; Ding, S. Small molecules enable cardiac reprogramming of mouse fibroblasts with a single factor, Oct4. Cell Rep. 2014, 6, 951-960.
32. Nam, Y. J.; Song, K.; Luo, X.; Daniel, E.; Lambeth, K.; West, K.; Hill, J. A.; DiMaio, J. M.; Baker, L. A.; Bassel-Duby, R.; et al. Reprogramming of human fibroblasts toward a cardiac fate. Proc. Natl. Acad. Sci. USA 2013, 110, 5588-5593.
33. Wada, R.; Muraoka, N.; Inagawa, K.; Yamakawa, H.; Miyamoto, K.; Sadahiro, T.; Umei, T.; Kaneda, R.; Suzuki, T.; Kamiya, K.; et al. Induction of human cardiomyocyte-like cells from fibroblasts by defined factors. Proc. Natl. Acad. Sci. USA 2013, 110, 12667-12672.
34. Fu, J. D.; Stone, N. R.; Liu, L.; Spencer, C. I.; Qian, L.; Hayashi, Y.; Delgado-Olguin, P.; Ding, S.; Bruneau, B. G.; Srivastava, D. Direct reprogramming of human fibroblasts toward a cardiomyocyte-like state. Stem Cell Rep. 2013, 1, 235-247.
35. Muraoka, N.; Ieda, M. Stoichiometry of transcription factors is critical for cardiac reprogramming. Circ. Res. 2015, 116, 216-218.
36. Inagawa, K.; Miyamoto, K.; Yamakawa, H.; Muraoka, N.; Sadahiro, T.; Umei, T.; Wada, R.; Katsumata, Y.; Kaneda, R.; Nakade, K.; et al. Induction of cardiomyocyte-like cells in infarct hearts by gene transfer of Gata4, Mef2c, and Tbx5. Circ. Res. 2012, 111, 1147-1156.
37. Mathison, M.; Singh, V. P.; Gersch, R. P.; Ramirez, M. O.; Cooney, A.; Kaminsky, S. M.; Chiuchiolo, M. J.; Nasser, A.; Yang, J.; Crystal, R. G.; et al. "Triplet" polycistronic vectors encoding Gata4, Mef2c, and Tbx5 enhances postinfarct ventricular functional improvement compared with singlet vectors. J. Thorac. Cardiovasc. Surg. 2014, 148, 1656-1664, e1652.
38. Zhang, Z.; Gao, Y.; Gordon, A.; Wang, Z. Z.; Qian, Z.; Wu, W. S. Efficient generation of fully reprogrammed human ips cells via polycistronic retroviral vector and a new cocktail of chemical compounds. PLoS ONE 2011, 6, e26592.
39. Carey, B. W.; Markoulaki, S.; Hanna, J.; Saha, K.; Gao, Q.; Mitalipova, M.; Jaenisch, R. Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc. Natl. Acad. Sci. USA 2009, 106, 157-162.
40. Carey, B. W.; Markoulaki, S.; Hanna, J. H.; Faddah, D. A.; Buganim, Y.; Kim, J.; Ganz, K.; Steine, E. J.; Cassady, J. P.; Creyghton, M. P.; et al. Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells. Cell Stem Cell 2011, 9, 588-598.
41. Kim, J.; Efe, J. A.; Zhu, S.; Talantova, M.; Yuan, X.; Wang, S.; Lipton, S. A.; Zhang, K.; Ding, S. Direct reprogramming of mouse fibroblasts to neural progenitors. Proc. Natl. Acad. Sci. USA 2011, 108, 7838-7843.
42. Thier, M.; Worsdorfer, P.; Lakes, Y. B.; Gorris, R.; Herms, S.; Opitz, T.; Seiferling, D.; Quandel, T.; Hoffmann, P.; Nothen, M. M.; et al. Direct conversion of fibroblasts into stably expandable neural stem cells. Cell Stem Cell 2012, 10, 473-479.
43. Zhu, S.; Ambasudhan, R.; Sun, W.; Kim, H. J.; Talantova, M.; Wang, X.; Zhang, M.; Zhang, Y.; Laurent, T.; Parker, J.; et al. Small molecules enable Oct4-mediated direct reprogramming into expandable human neural stem cells. Cell Res. 2014, 24, 126-129.
44. Li, J.; Huang, N. F.; Zou, J.; Laurent, T. J.; Lee, J. C.; Okogbaa, J.; Cooke, J. P.; Ding, S. Conversion of human fibroblasts to functional endothelial cells by defined factors. Arterioscler. Thromb. Vasc. Biol. 2013, 33, 1366-1375.
45. Li, K.; Zhu, S.; Russ, H. A.; Xu, S.; Xu, T.; Zhang, Y.; Ma, T.; Hebrok, M.; Ding, S. Small molecules facilitate the reprogramming of mouse fibroblasts into pancreatic lineages. Cell Stem Cell 2014, 14, 228-236.
46. Moretti, A.; Caron, L.; Nakano, A.; Lam, J. T.; Bernshausen, A.; Chen, Y.; Qyang, Y.; Bu, L.; Sasaki, M.; Martin-Puig, S.; et al. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 2006, 127, 1151-1165.
47. Maza, I.; Caspi, I.; Zviran, A.; Chomsky, E.; Rais, Y.; Viukov, S.; Geula, S.; Buenrostro, J. D.; Weinberger, L.; Krupalnik, V.; et al. Transient acquisition of pluripotency during somatic cell transdifferentiation with ipsc reprogramming factors. Nat. Biotechnol. 2015, 33, 769-774.
48. Bar-Nur, O.; Verheul, C.; Sommer, A. G.; Brumbaugh, J.; Schwarz, B. A.; Lipchina, I.; Huebner, A. J.; Mostoslavsky, G.; Hochedlinger, K. Lineage conversion induced by pluripotency factors involves transient passage through an iPSC stage. Nat. Biotechnol. 2015, 33, 761-768.
49. Pang, Z. P.; Yang, N.; Vierbuchen, T.; Ostermeier, A.; Fuentes, D. R.; Yang, T. Q.; Citri, A.; Sebastiano, V.; Marro, S.; Sudhof, T. C.; et al. Induction of human neuronal cells by defined transcription factors. Nature 2011, 476, 220-223.
50. Qian, L.; Huang, Y.; Spencer, C. I.; Foley, A.; Vedantham, V.; Liu, L.; Conway, S. J.; Fu, J. D.; Srivastava, D. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 2012, 485, 593-598.
51. Zeisberg, E. M.; Kalluri, R. Origins of cardiac fibroblasts. Circ. Res. 2010, 107, 1304-1312.
52. Mathison, M.; Gersch, R. P.; Nasser, A.; Lilo, S.; Korman, M.; Fourman, M.; Hackett, N.; Shroyer, K.; Yang, J.; Ma, Y.; et al. In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor. J. Am. Heart Assoc. 2012, 1, e005652.
53. Jayawardena, T. M.; Finch, E. A.; Zhang, L.; Zhang, H.; Hodgkinson, C.; Pratt, R. E.; Rosenberg, P. B.; Mirotsou, M.; Dzau, V. J. MicroRNA induced cardiac reprogramming in vivo: Evidence for mature cardiac myocytes and improved cardiac function. Circ. Res. 2015, 116, 418-424.
54. Torper, O.; Pfisterer, U.; Wolf, D. A.; Pereira, M.; Lau, S.; Jakobsson, J.; Bjorklund, A.; Grealish, S.; Parmar, M. Generation of induced neurons via direct conversion in vivo. Proc. Natl. Acad. Sci. USA 2013, 110, 7038-7043.
55. Pfisterer, U.; Kirkeby, A.; Torper, O.; Wood, J.; Nelander, J.; Dufour, A.; Bjorklund, A.; Lindvall, O.; Jakobsson, J.; Parmar, M. Direct conversion of human fibroblasts to dopaminergic neurons. Proc. Natl. Acad. Sci. USA 2011, 108, 10343-10348.
56. Caiazzo, M.; Dell'Anno, M. T.; Dvoretskova, E.; Lazarevic, D.; Taverna, S.; Leo, D.; Sotnikova, T. D.; Menegon, A.; Roncaglia, P.; Colciago, G.; et al. Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature 2011, 476, 224-227.
57. Srivastava, D.; Berry, E. C. Cardiac reprogramming: From mouse toward man. Curr. Opin. Genet. Dev. 2013, 23, 574-578.
58. Kormann, M. S.; Hasenpusch, G.; Aneja, M. K.; Nica, G.; Flemmer, A. W.; Herber-Jonat, S.; Huppmann, M.; Mays, L. E.; Illenyi, M.; Schams, A.; et al. Expression of therapeutic proteins after delivery of chemically modified mRNA in mice. Nat. Biotechnol. 2011, 29, 154-157.
59. Miki, K.; Yoshida, Y.; Yamanaka, S. Making steady progress on direct cardiac reprogramming toward clinical application. Circ. Res. 2013, 113, 13-15.
60. Kuppusamy, K. T.; Jones, D. C.; Sperber, H.; Madan, A.; Fischer, K. A.; Rodriguez, M. L.; Pabon, L.; Zhu, W. Z.; Tulloch, N. L.; Yang, X.; et al. Let-7 family of microrna is required for maturation and adult-like metabolism in stem cell-derived cardiomyocytes. Proc. Natl. Acad. Sci. USA 2015, 112, E2785-E2794.
61. Nahrendorf, M.; Pittet, M. J.; Swirski, F. K. Monocytes: Protagonists of infarct inflammation and repair after myocardial infarction. Circulation 2010, 121, 2437-2445.